The deal is part of a broader effort by the Trump administration to press Latin American countries to agree to joint operations inside their borders.

A first-of-its-kind drug for hepatitis B is letting some patients stop treatment without showing signs of the dangerous liver virus, what’s called a “functional cure,” researchers reported Thursday. In two international studies,

Several weeks after NBC News reached out to Anthem Blue Cross Blue Shield about the denial, the insurer changed its policy to include coverage of deep brain stimulation for certain children.

In clinical trials, the drug was shown to almost double the survival time for pancreatic cancer patients. Here's how it works and who can get it.

(Corrects to clarify the total number of patients in the study in paragraph 10) May 27 (Reuters) - The U.S. Food and Drug Administration on Wednesday approved AbbVie's drug to treat blastic plasmacytoid dendritic cell neoplasm (BPDCN),

LUCENA CITY — Police arrested two alleged high-value drug suspects and seized suspected “shabu” (crystal meth) worth up to P2.1 million during a buy-bust operation in Tiaong, Quezon, on Thursday. Colonel Romulo Albacea,

Drugmaker Eli Lilly is testing a new experimental drug that could be a game changer in treating high cholesterol, it said. Researchers say the new drug, called VERVE-102, could be administered to patients with a one-time infusion over the course of approximately four hours instead of having patients take a daily pill or regular shots.

By Bhanvi Satija LONDON, May 28 (Reuters) - GSK said its experimental chronic hepatitis B drug helped nearly one in five patients achieve a functional cure in late-stage studies, raising hopes for a finite treatment course as an alternative to lifelong antiviral pills.